Research programme: arthritis therapeutic - EyegeneAlternative Names: Degenerative arthritis therapeutic - Eyegene; Osteoarthritis therapeutic - Eyegene
Latest Information Update: 05 Feb 2014
At a glance
- Originator EyeGene
- Class Gene therapies
- Mechanism of Action Gene expression modulators; Homeodomain protein modulators
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Research Osteoarthritis
Most Recent Events
- 01 Jan 2014 Early research in Osteoarthritis in South Korea (unspecified route)